# Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis

> **NCT01149707** · PHASE2 · COMPLETED · sponsor: **PurGenesis Technologies Inc.** · enrollment: 34 (actual)

## Conditions studied

- Left-Sided Ulcerative Colitis
- Proctosigmoiditis

## Interventions

- **DRUG:** PUR 0110 Rectal Enema 250 mg
- **DRUG:** PUR 0110 Rectal Enema 500 mg
- **DRUG:** PUR 0110 Rectal Enema 1000 mg
- **DRUG:** Placebo Enema

## Key facts

- **NCT ID:** NCT01149707
- **Lead sponsor:** PurGenesis Technologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06-01
- **Primary completion:** 2014-10-01
- **Final completion:** 2015-06-20
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2018-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01149707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01149707, "Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01149707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*